David A. Siegel Biolife Solutions Inc Transaction History

Two Sigma Advisers, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$10.54 - $24.2 $52,699 - $121,000	5,000 Added 36.23%	18,800 $260,000
Q1 2022 May 16, 2022	BUY	$20.81 - $37.29 $287,178 - $514,602	13,800 New	13,800 $314,000
Q2 2021 Aug 16, 2021	SELL	$29.51 - $44.62 $675,779 - $1.02 Million	-22,900 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$32.95 - $44.24 $754,555 - $1.01 Million	22,900 New	22,900 $824,000
Q1 2019 May 15, 2019	SELL	$10.9 - $21.26 $282,310 - $550,634	-25,900 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$9.5 - $17.17 $86,450 - $156,247	9,100 Added 54.17%	25,900 $312,000
Q3 2018 Nov 14, 2018	BUY	$14.99 - $25.48 $68,954 - $117,208	4,600 Added 37.7%	16,800 $294,000
Q2 2018 Aug 14, 2018	BUY	$6.18 - $13.49 $75,396 - $164,578	12,200 New	12,200 $139,000

188

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.12B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.